66.0.1. For the purposes of sections 57 and 58 of the Act respecting prescription drug insurance (chapter A-29.01), the Board shall, on request, forward the information referred to in section 59 of that Act to the Conseil consultatif de pharmacologie.
1994, c. 8, s. 13; 1996, c. 32, s. 99.